ArticleJugan geon-gang gwa jilbyeong2025
[Incidence and Characteristics of Hepatitis C Virus in Busan Metropolitan City, Ulsan Metropolitan City, and Gyeongsangnam-do, Republic of Korea, 2018-2023].
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization has proposed the Global Health Sector Strategy aimed at eliminating viral hepatitis (hepatitis B and C). In response, the Republic of Korea (ROK) established the "First Basic Plan for the Management of Viral Hepatitis (hepatitis B and C), 2023-2027." This report analyzes hepatitis C data from the Gyeongnam region (including Busan, Ulsan, and Gyeongsangnam-do) over the last six years, based on case reports and epidemiological investigations collected since hepatitis C surveillance became mandatory. From 2018 to 2023, 14,256 hepatitis C cases, both patients and pathogen carriers, were reported in the Gyeongnam region through the Disease and Health Integrated Management System. The incidence rate per 100,000 population increased from 29.3 cases in 2018 to 40.9 cases in 2020, peaked, and then steadily decreased to 22.7 cases in 2023. The age-standardized incidence rates in Busan (1.6 to 2.0 times) and Gyeongsangnam-do (1.3 to 1.7 times) were significantly higher than the national average. The highest incidence was observed in individuals in their 50s (30.6%) and 60s (24.1%), with housewives (18.4%) being the most common occupation. The primary testing indication was hospitalization for other conditions (2.7%), highlighting the need for early screening and management of hospitalized patients. The most prevalent genotypes were type 1b (8.5%) and type 2 (4.0%), consistent with the most common genotypes reported in the ROK. These findings will guide the development of hepatitis C prevention and management strategies in the Gyeongnam region. In future, identifying high-prevalence areas and risk factors, along with expanding community-based screening and treatment programs, will aid in eliminating hepatitis C.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.